Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis

201734 citationsJournal Article

Authors

Samuel M. Rubinstein · Vanderbilt University Medical Center

Robert F. Cornell · Vanderbilt University Medical Center

Liping Du · Vanderbilt University

Beatrice P. Concepcion · Vanderbilt University Medical Center

Stacey Goodman · Vanderbilt University Medical Center

Shelton Harrell · Vanderbilt University Medical Center

Sara Horst

Abstract

Using a 12-month landmark analysis, AS correlated with progression to ESKD. These data suggest that a kidney biopsy, in addition to providing diagnostic information, can be the basis for a pathologic scoring system with prognostic significance.

Topics & Keywords

Amyloidosis: Diagnosis, Treatment, Outcomes Dermatological and Skeletal Disorders Parathyroid Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Amyloid

Volume 24, Issue 3, pp. 205-211

DOI: 10.1080/13506129.2017.1360272

Field-Weighted Citation Impact: 0.34